Mechanical circulatory support as a bridge to cancer therapy in patients with end stage heart failure: a single center experience

Key Takeaways for GI Nurses

• Patients with mechanical circulatory support devices may present for endoscopic procedures as part of their cancer screening or treatment protocol, requiring specialized knowledge of device management and anticoagulation considerations
• Understanding the complex medication regimens and hemodynamic status of patients bridged to cancer therapy is crucial for safe procedural planning and post-procedure monitoring
• Multidisciplinary coordination between cardiology, oncology, and gastroenterology teams becomes essential when managing these high-acuity patients in the endoscopy suite
• Enhanced preprocedural assessment protocols may be needed to evaluate bleeding risk and optimize timing of GI interventions in this vulnerable patient population

Clinical Relevance

This research highlights an emerging patient population that GI and endoscopy nurses will increasingly encounter as mechanical circulatory support technology advances and survival rates improve. Patients with ventricular assist devices or other mechanical support who are being bridged to cancer therapy represent a unique challenge in the endoscopy setting. These patients often require complex anticoagulation management, have altered hemodynamics, and may present with bleeding complications that necessitate urgent endoscopic intervention. Understanding the interplay between cardiac support devices, cancer treatment protocols, and gastrointestinal procedures is becoming essential knowledge for advanced practice endoscopy nurses.

From an operational standpoint, caring for these patients requires enhanced communication protocols between multiple specialties and may necessitate modifications to standard preprocedural workflows. Endoscopy units may need to develop specific guidelines for device management during procedures, establish clear protocols for anticoagulation reversal in emergency situations, and ensure appropriate monitoring equipment is available. The complexity of these cases also emphasizes the importance of having experienced nursing staff who can recognize early signs of hemodynamic compromise and respond appropriately to device-related complications during endoscopic procedures.

This patient population also underscores the evolving role of the GI nurse in comprehensive patient assessment and care coordination. As more patients with mechanical circulatory support survive to develop secondary conditions requiring endoscopic evaluation or treatment, nurses must develop competencies in understanding how these devices function, their impact on bleeding risk, and the implications for procedural planning and recovery.

Bottom Line

As mechanical circulatory support becomes more prevalent as a bridge to cancer therapy, GI and endoscopy nurses must prepare for an increasingly complex patient population requiring specialized knowledge of device management, enhanced multidisciplinary coordination, and modified procedural protocols to ensure safe and effective endoscopic care in these high-risk patients.